Evidence map›Paper›PMID 23314570›Full record

ArticleVirulence2013

The mutated staphylococcal H35A α-toxin inhibits adhesion and invasion of Staphylococcus aureus and group A streptococci.

Junshu Yang, Xudong Liang, Yinduo Ji

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Junshu YangDepartment of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA.
Xudong Liang
Yinduo Ji
University of Minnesota · US

Funding

A Novel Essential Regulator of Staphylococcus aureusR01AI057451 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JI, YINDUO · 2005 to 2008
$969k
Novel antibacterial target: an essential glycoproteaseR21AI065740 · NIAID · UNIVERSITY OF MINNESOTA · PI JI, YINDUO · 2006 to 2007
$403k
NIAID NIH HHS AI057451NIAID NIH HHS AI065740NIAID NIH HHS R01 AI057451NIAID NIH HHS R21 AI065740
6 · The paper itself

Abstract

In previous studies we demonstrated that the staphylococcal α-toxin inhibits adhesion and invasion of S. aureus by epithelial cells through binding to α5β1 integrin, a receptor of fibronectin. Moreover, we revealed that a H35A mutation abolishes the cytotoxicity of α-toxin completely. These findings led us to hypothesize that the H35A mutated α-toxin may be explored as a potential inhibitor for bacterial adhesion and invasion of epithelial cells. In this study, we examined the impact of the H35A α-toxin on staphylococcal capacity of adhering to and invading into epithelial cells and found that the addition of H35A α-toxin in the culture medium dramatically inhibited S. aureus' ability to adhere to and internalize into epithelial cells. Importantly, we demonstrated that both the staphylococcal α-toxin and H35A mutated α-toxin are capable of retarding the adhesion and invasion of epithelial cells by Streptococcus pyogenes. These findings suggest that the H35A toxoid has the potential to be utilized as an inhibitor of S. aureus and S. pyogenes ability to adhere to and invade epithelial cells.

Indexed as

Amino Acid SubstitutionAnti-Bacterial AgentsBacterial AdhesionBacterial ToxinsCell LineEndocytosisEpithelial CellsHemolysin ProteinsHumansMutant ProteinsMutation, MissenseStaphylococcus aureusStreptococcus pyogenesToxoidsAnti-Bacterial AgentsBacterial ToxinsHemolysin ProteinsMutant Proteinsstaphylococcal alpha-toxinToxoids

Identifiers

PMID23314570
PMCPMC3544751
OpenAlexW2162023384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.